ImmunoCellular Therapeutics, Ltd. (IMUC)
21900 Burbank, 3rd Floor
Woodland Hills, CA 91367
ImmunoCellular Theraputics, Ltd., is a clinical-stage biotechnology company that is focused on developing new immune-based products to treat and diagnose cancer.
Our products and technologies are designed to harness the power of the immune system to improve the treatment and diagnosis of cancer. We are developing active immunotherapies that target not only regular tumor cells, but also the cancer stem cells believed to cause cancer growth and recurrence. Using our proprietary discovery technology, we also identify and develop monoclonal antibodies that may be used to treat and diagnose a wide range of cancers. Our most advanced clinical programs are in glioblastoma multiforme, but our product candidates also have potential applications in many other cancers with high unmet medical need.
Press Releases: http://imuc.com/press/
FDA clinical trial in progress: http://www.imuc.com/trial
U.S. Stock Transfer Corp.
Glendale, CA 91204-2991
Gary Nash, CEOcast, Inc.
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn't a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp